Strategy

Biotechonomy is a life science venture capital firm that provides equity financing and management assistance to start-up and early stage, entrepreneurial companies. We focus on companies that are leaders in their domain, are in undervalued sectors, or are strategically positioned to take advantage of near-term trends and industry sea-changes. These include companies engaged in genomics-based energy, industrial and agricultural opportunities; companies with technologies that accelerate drug discovery and development; and businesses capable of improving the diagnosis and treatment of disease.

Our Team

In addition to Juan Enriquez, Caleb M. Winder is also a principal at Biotechonomy.  He serves on the board of Xcellerex, Inc.

Caleb M. Winder spent his early career as an award-winning sales and marketing professional for companies that specialized in medical equipment, diagnostics systems and software. They include Midmark Corporation, the world leader in Medical Exam table manufacturing, Medical Graphics Corporation, a manufacturer and distributor of innovative cardio-respiratory systems, and Moldflow Corporation, a developer of predictive computer-aided engineering software and process monitoring software for injection-molded plastic parts. Prior to business school, he was in Business Development for GeneXP Biosciences, where he set up a 'greenfield' biotech manufacturing plant, developed investor presentations and coordinated the company's third round of equity financing.

During the summer of 2003, Mr. Winder was recruited by Seed Partners, an angel-stage investment fund, to provide due diligence and consulting to several startups.

Mr. Winder received his MBA from Babson College, magna cum laude, where he was a Babson Fellow, Director of the Entrepreneurial Finance Group and a team member of Babson's entry into the Venture Capital Investment Competition. He received a BA in Biology with a minor in Economics from Colby College.